[1]
2023. Design, Synthesis and Evaluation of CNS Depressant Activity of 2-(Substituted Aryl)-Piperazine-3-Phenyl-4(3H)-Quinazolinone. International Journal of Pharmaceutical Sciences and Drug Research. 15, 2 (Mar. 2023), 209–213. DOI:https://doi.org/10.25004/IJPSDR.2023.150213.